VIVEK SUBBIAH to Hypertension
This is a "connection" page, showing publications VIVEK SUBBIAH has written about Hypertension.
Connection Strength
0.139
-
Efficacy of Selpercatinib in RET Fusion-Positive Non-Small-Cell Lung Cancer. N Engl J Med. 2020 08 27; 383(9):813-824.
Score: 0.096
-
Efficacy of Selpercatinib in RET-Altered Thyroid Cancers. N Engl J Med. 2020 08 27; 383(9):825-835.
Score: 0.024
-
The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma. Br J Cancer. 2017 05 23; 116(11):1402-1407.
Score: 0.019